Wall Street isn't giving these stocks much love, but I think they could have very bright futures.
BIOQUAL, Inc. (OTC Pink: BIOQ) (www.bioqual.com):
AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a+" of MAPFRE Panamá S.A. (MAPFRE Panamá) (Panama City, Panama). The outlook of these Credit Ratings (ratings) is stable.
This inaugural report highlights unprecedented shifts in DTC wine ecommerce over the past year, and looks ahead at what's to come in 2021.
Cloud Based Event Management Market Research Report by Component (Services and Software), by End-User (Corporate, Education, Event Organizers and Planners, and Government) - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cloud Based Event Management Market Research Report by Component, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913855/?utm_source=GNW The Global Cloud Based Event Management Market is expected to grow from USD 3,823.91 Million in 2019 to USD 8,253.02 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.68%. Market Segmentation & Coverage: This research report categorizes the Cloud Based Event Management to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Component, the Cloud Based Event Management Market studied across Services and Software. The Services further studied across Consulting, Deployment and Integration, Managed Services, and Support and Maintenance. The Software further studied across Analytics and Reporting Software, Content Management Software, Event Marketing Software, Event Planning Software, Event Registration and Ticketing Software, Onsite Technology, Venue Management Software, and Visitor Management Software. Based on End-User, the Cloud Based Event Management Market studied across Corporate, Education, Event Organizers and Planners, and Government. Based on Geography, the Cloud Based Event Management Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cloud Based Event Management Market including Arlo, Artifax Software, Attendica Eventworks, Aventri, Cvent, Entrinsik, Envisage Engagement Technologies, EventBH, Extreme Impact, Mitingu, MLeads, Naos, and Ya Ya Regie. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cloud Based Event Management Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market. The report provides insights on the following pointers: 1\. Market Penetration: Provides comprehensive information on the market offered by the key players 2\. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3\. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4\. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5\. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments The report answers questions such as: 1\. What is the market size and forecast of the Global Cloud Based Event Management Market? 2\. What are the inhibiting factors and impact of COVID-19 shaping the Global Cloud Based Event Management Market during the forecast period? 3\. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cloud Based Event Management Market? 4\. What is the competitive strategic window for opportunities in the Global Cloud Based Event Management Market? 5\. What are the technology trends and regulatory frameworks in the Global Cloud Based Event Management Market? 6\. What are the modes and strategic moves considered suitable for entering the Global Cloud Based Event Management Market? Read the full report: https://www.reportlinker.com/p05913855/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
It is hard to get excited after looking at Thermon Group Holdings' (NYSE:THR) recent performance, when its stock has...
during the forecast period. The major factors driving the market include the increasing number of security breaches and cyberattacks resulting in huge financial losses, and stringent government regulations towards adoption of cyber insurance policies.New York, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cyber Insurance Market by Component, Type, Coverage, Organization Size, End User And Region - Global Forecast to 2025" - https://www.reportlinker.com/p05977659/?utm_source=GNW • By insurance coverage, the cyber liability segment expected to hold a larger market size in 2025 Cyber risk insurance or cyber liability insurance coverage helps an organization cover the cost to recover from a data breach, virus, or other cyber-attacks.Cyber liability insurance covers expenses related to first parties and also third-party claims. The cyber insurance policy covers some reimbursable expenses such as investigation, business losses, lawsuits and extortion, and privacy and notification.The growing sophistication of cyber-attacks and stringent regulatory mandates persuade enterprises to proactively adopt cyber insurance solutions. Cyber liability coverage policies can assist insurers to offer first party and third part cyber coverage to prevent from the post effects of a security breach that could result in critical business losses. Key vendors offering various types of cyber insurance solutions include Allianz Group, AIG, Chubb, Aon, Zurich, AXA, and Berkshire Hathaway, among others APAC to register the highest growth rate during the forecast period Asia Pacific (APAC) comprises of emerging economies, such as Australia and New Zealand, China, Singapore, and Japan, with developed security infrastructure.Machine Learning (ML), Internet of Things (IoT), big data analytics, and Artificial Intelligence (AI) are emerging methodologies that are being deployed in this region. APAC is home to large number of established Small and Medium-sized Enterprises (SMEs), which are growing at laudable pace to cater to their large customer base.SMEs are rapidly adopting cyber insurance solutions to manage their enterprise data. Despite the growing importance of SMEs in this region, they are most affected mostly by cyber and malware attacks owing to budgetary constraints and resource shortages. • By Company Type: Tier 1 – 55%, Tier 2 – 27%, and Tier 3 – 18% • By Designation: C-level – 33%, D-level – 25%, and Others – 42% • By Region: North America – 38%, Europe – 14%, APAC – 19%, RoW – 29% The technology vendors covered in the cyber insurance market report include BitSight (US), Prevalent (US), RedSeal (US), SecurityScorecard (US), Cyber Indemnity Solutions (Australia), Cisco (US), UpGuard (US), Microsoft (US), Check Point (US), AttackIQ (US), SentinelOne (US), Broadcom (US), Accenture (Ireland), Kenna Security (US), Cylance (US), FireEye (US), CyberArk (US), CYE (Israel), SecurIT360 (US), and Founder Shield (US).The insurance vendors covered in the cyber insurance market are Allianz (Germany), AIG (US), Aon (UK), Arthur J. Gallagher & Co (US), Travelers Insurance (US), AXA XL (US), AXIS Capital (Bermuda), Beazley (UK), Chubb (Switzerland), CNA Financial (US), Fairfax Financial (Canada), Liberty Mutual (US), Lloyd’s of London (UK), Lockton (US), Munich Re Group (Germany), and Sompo International (Bermuda). The startup vendors covered in the cyber insurance market are At-Bay (US), Cybernance (US), CyberCube (US), Coalition (US), Arceo.ai (US), Kovrr (Israel), Sayata Labs (Israel), Zeguro (US), RiskSense (US), Cyence (US), SafeBreach (US), and Cronus Cyber Technologies (Israel). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches and product enhancements, and acquisitions to expand their footprint in the cyber insurance market. Research Coverage The market study covers the cyber insurance market size across different segments.It aims at estimating the market size and the growth potential across different segments, including application, service model, security type, organization size, vertical, and region. The study further includes an in-depth competitive analysis of the leading market players, along with their company profiles, key observations related to product and business offerings, recent developments, and market strategies. Key Benefits of Buying the Report The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the global cyber insurance market and its subsegments.This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and to plan suitable go-to-market strategies. Moreover, the report will provide insights for stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities. Read the full report: https://www.reportlinker.com/p05977659/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The board of directors of Essential Utilities Inc. (NYSE: WTRG) today declared a quarterly cash dividend of $0.2507 per share, payable Dec. 1, 2020 to all shareholders of record on Nov. 13, 2020.
OTTAWA, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Cardiovascular disease (CVD) is the country’s leading cause of premature death in women. The Canadian Women’s Heart Health Alliance (CWHHA), a national network of women’s heart health experts and advocates powered by the Canadian Women’s Heart Health Centre (CWHHC) at the University of Ottawa Heart Institute (UOHI), released eye-opening research this week revealing the scope of the problem. The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 2: Scope of the Problem is published in the Canadian Journal of Cardiology Open. It is the second chapter in a series of nine to be published chronologically within the year.“The Canadian Women’s Heart Health Alliance ATLAS aims to guide clinicians and the public in recognizing the unique aspects of women’s heart health care while providing policy makers with information they need to ensure equitable care for women with CVDs,” says Dr. Colleen Norris, a professor in the Faculty of Nursing at the University of Alberta and scientific director of the Cardiovascular Health & Stroke Strategic Clinical Network with Alberta Health Services. Dr. Norris chairs the CWHHA’s Health Systems and Policy Working Group and is the paper’s senior author. “Most people are unaware that cardiovascular conditions are a woman’s main health threat, leading to more hospitalizations and deaths every year than other health conditions. In Chapter 2 of the ATLAS, we summarize the impacts of CVDs among Canadian women, we highlight sex and gender gaps in research and treatment, and, we look at how being female overlaps with other factors that affect CVD outcomes in women, including Indigenous identity, ethnicity, disability, and socioeconomic status.”Some of the key findings are highlighted below: * Coronary artery disease (CAD), including myocardial infarction (heart attack), and followed by stroke, are accountable for most CVD-related deaths in women. * Most emergency department visits and hospitalizations by women are due to CAD, heart failure, and stroke. * Indigenous women in Canada experience increased CVD, linked to colonization and subsequent social, economic and political challenges. * Women from racial and ethnic backgrounds (i.e., South Asian, Afro-Caribbean, Hispanic, and Chinese North-American women) have greater CVD risk factors, and CVD risk in East Asian women increases with duration of stay in Canada. * Canadians living in northern, rural, remote and on-reserve residences experience greater CVD morbidity, mortality and risk factors. * Increase in CVD risk among Canadian women has been linked with lower socioeconomic status background and women with disabilities have an increased risk of adverse cardiac events.“In the year 2020, women continue to be under-aware, under-researched, under-diagnosed, and under-treated when it comes to cardiovascular conditions,” says Dr. Thais Coutinho, head of the Division of Cardiac Prevention and Rehabilitation at the University of Ottawa Heart Institute, chair of the CWHHC, and chair of the CWHHA’s Executive Steering Committee. “The Canadian Women’s Heart Health Alliance ATLAS is the most comprehensive review of its kind, summarizing the state of women’s heart health in Canada. Chapter 2 forms the foundation of information required by policy-makers, clinicians, and the public to ensure better research, greater advocacy, faster diagnosis, better prevention and treatment, and improved quality of life for women with CVD.”The release of ATLAS Chapter 2 falls ahead of this year’s Canadian Cardiovascular Congress, running virtually from October 21 through to October 24. At this year’s congress, Dr. Coutinho will co-chair a workshop (HerHeartMatters2020: Women’s Cardiovascular Health: Identifying and Managing Sex-Specific Risk and Disease) in which Alliance members will discuss practical and clinically applicable topics that highlight specific risk periods in a woman’s lifespan and their associated female-specific risk factors.To close the workshop, the ATLAS’ leads, Dr. Colleen Norris and Dr. Sharon Mulvagh, co-director of the Women’s Heart Health Clinic at Queen Elizabeth II’s Health Sciences Centre in Halifax, NS, and chair of the CWHHA’s Knowledge Translation and Mobilization Working Group, will share details about their work and the role of ATLAS Chapter 2 as a foundational piece to motivate policy and practice changes in Canada and beyond.ABOUT THE CANADIAN WOMEN’S HEART HEALTH ALLIANCEThe Canadian Women's Heart Health Alliance is a volunteer organization of over 65 health professionals and patients that was established in 2018 to address the gaps in cardiovascular care for women and improve their cardiovascular health across the lifespan. Patients, clinicians, researchers, trainees and policymakers work collaboratively to move knowledge to action, to transform clinical practice, and to impact public policy in the field of women’s cardiovascular health. Ongoing coordination of the Alliance is provided by the Canadian Women's Heart Health Centre at the University of Ottawa Heart Institute.ABOUT THE CANADIAN WOMEN’S HEART HEALTH CENTREThe Canadian Women’s Heart Health Centre is dedicated to sparking the social change needed to close the gaps and ensure women are as well-informed and well-cared for as men. Our vision is to provide leadership in the development, implementation and evaluation of cardiovascular prevention and management strategies to improve women’s heart health. Our goal is to improve the prevention, detection, and management of heart disease in Canadian women.ABOUT THE UNIVERSITY OF OTTAWA HEART INSTITUTEThe University of Ottawa Heart Institute has flourished into one of Canada’s most distinguished heart health centres for the unparalleled care it provides to its patients, a world-renowned research institute that brings science from bench to bedside, and the country’s main influencer when it comes to preventing heart disease. Its promise remains the very pillar on which it was built: Always putting patients first.To conduct an interview with the authors of the paper or spokespersons from the University of Ottawa Heart Institute, media are invited to contact the liaison named below.MEDIA CONTACT:Leigh B. Morris Communications Officer University of Ottawa Heart Institute 613-316-6409 (cell) email@example.com
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2020 (GLOBE NEWSWIRE) -- JAGGAER has been recognized by leading research firm Gartner as a Leader in its 2020 Gartner Magic Quadrant for Procure-to-Pay Suites, improving its position in the Magic Quadrant on the completeness of vision axis compared to the previous year. Gartner identified that, “Growing pressure to reduce spend, drive compliance and improve efficiency continues to propel interest in the P2P suite market. By 2025, organizations using P2P suites will save 30% year over year on goods and services costs through network price benchmarking and discounts.”“We are delighted that we have improved our position on the completeness of vision axis in the Leaders quadrant in the Gartner P2P Suites Magic Quadrant,” JAGGAER CEO Jim Bureau commented. “JAGGAER is accelerating our product development efforts to add new levels of intelligence to the offering, further improving the customer experience.”You can download a complimentary copy of the October 2020 Gartner Magic Quadrant for Procure-to-Pay Suites here.Disclaimer: Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.About JAGGAER: Procurement SimplifiedJAGGAER is the world’s largest independent spend management company, connecting customers to a network of 4 million suppliers in 70 countries, served by offices located in the Americas, APAC, Asia and EMEA. JAGGAER offers end-to-end SaaS-based procurement solutions, including advanced Spend Analytics, Category Management, Supplier Management, Sourcing, Contracts, eProcurement, Invoicing, Supply Chain Management and Inventory Management. These all reside on a single platform, JAGGAER ONE. JAGGAER has pioneered spend solutions for more than two decades and continues to lead the innovation curve by listening to customers and stakeholders in all industry sectors, public services and academia. JAGGAER holds 37 patents – more than any other spend management company.JAGGAER Media ContactAbigail Holmes Corporate Ink for JAGGAER firstname.lastname@example.org +1 617.969.9192
Masked up, quarantined and hearing none of the usual boos, MLB's umpires have traversed a pandemic-altered season in the way they prefer: Under the radar.
SeriesRIKB 22 1026RIKS 26 0216 ISINIS0000020717IS0000030732 Maturity Date10/26/202202/16/2026 Auction Date10/23/202010/23/2020 Settlement Date10/28/202010/28/2020 Buyback issueRIKS 21 0414 Buyback price (clean)102.2790 On the Auction Date, between 13:30 a.m. and 14:00 a.m., the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury Bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day.The value of the buyback issue, together with accrued interest and indexation, will constitute payment for the new issued bonds.No special compensation is paid in relations to purchase of RIKS 21 0414It should be noted that cash is not accepted. Payment may only be made with the buyback issue at the buyback price.For further information, please refer to the Government Debt Management website, i.e. for the description of the Treasury bond and the General Terms of Auction of Treasury Bonds.For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.
If you've bought a house, leased an apartment, or signed a legal agreement recently, it's likely you didn't use a pen and paper. With the world adopting social distancing practices, signing documents in person is quickly becoming a thing of the past, and DocuSign's (NASDAQ: DOCU) leading e-signature product is picking up the slack. DocuSign's flagship product is its e-signature service.
Shares of clinical-stage biotech CRISPR Therapeutics (NASDAQ: CRSP) are down an eye-popping 12% as of 12:05 p.m. EDT Wednesday. The biotech's shares sank in response to a patient death in an early stage study assessing the company's off-the-shelf T-cell therapy, CTX110, in patients with CD19+ B-cell malignancies (blood cancers). The patient in question was the only one to receive the highest dosage of the experimental cell therapy in the study.
The "Shrink Wrap Equipment - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
Brazilian President Jair Bolsonaro said Wednesday his government would not in fact purchase a Chinese-developed vaccine against Covid-19, a day after his health minister announced a deal to buy millions of doses.
Washington, DC, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, announced today the election of its 2021 Officers, Executive Committee, and Board of Directors. The Executive Committee and Board of Directors oversee the formation and execution of ARM’s strategic priorities and focus areas over the coming year. The committee and board are subject to an annual re-election or rotation process, with nominations and approval by the ARM membership and current Board."We are pleased to welcome such an accomplished group of executives to the 2021 ARM board of directors," said Janet Lambert, CEO of ARM. "As scientists, commercial leaders, and regulatory experts, the new members of the board will be instrumental in helping ARM and its members deliver transformative and potentially curative regenerative medicines to patients around the world." ARM 2021 Officers:Emile Nuwaysir, Ph.D. – President and CEO, BlueRock Therapeutics (Chairman)Usman ‘Oz’ Azam, M.D. – President and CEO, Tmunity Therapeutics (Vice Chairman)Amy Butler, Ph.D. – President, Biosciences, Thermo Fisher Scientific (Secretary)Devyn Smith, Ph.D. – COO, Sigilon Therapeutics (Treasurer)ARM 2021 Executive Committee: *new to the Executive Committee for 2021Usman ‘Oz’ Azam, M.D. – President and CEO, Tmunity TherapeuticsAmy Butler, Ph.D. – President, Biosciences, Thermo Fisher Scientific * Miguel Forte, M.D., Ph.D. – CEO, Bone TherapeuticsClaudia Mitchell, MBA, Ph.D. – SVP, Product and Portfolio Strategy, Astellas PharmaEmile Nuwaysir, Ph.D. – President and CEO, BlueRock Therapeutics Bob Smith, MBA – SVP, Global Gene Therapy Business, Pfizer Inc.Devyn Smith, Ph.D. – COO, Sigilon Therapeutics* Arthur Tzianabos, Ph.D. – President and CEO, Homology Medicines* Christopher Vann – COO, Autolus Therapeutics ARM 2021 Board of Directors: *new to the Board for 2021Usman ‘Oz’ Azam, M.D. – President and CEO, Tmunity TherapeuticsRonald Bartek – Co-Founder and President, Friedreich’s Ataxia Research AllianceAmy Butler, Ph.D. – President, Biosciences, Thermo Fisher ScientificBradley Campbell, MBA – President and COO, Amicus TherapeuticsCindy Collins, MBA – President and CEO, Editas Medicine* Maria Fardis, Ph.D., MBA – President and CEO, Iovance BiotherapeuticsMiguel Forte, M.D., Ph.D. – CEO, Bone TherapeuticsJonathan Garen, M.S. – CBO, uniQure* Bobby Gaspar, M.D., Ph.D. – CEO, Orchard TherapeuticsMichael Hunt, ACA – CFO, ReNeuronJerry Keybl, Ph.D. – Senior Director, Cell & Gene Therapy, MilliporeSigma* Louise Rodino-Klapac, Ph.D. – SVP, Gene Therapy, Sarepta TherapeuticsAnn Lee, Ph.D. – SVP and Head of Cell Therapy Development & Operations, Bristol Myers Squibb* Dave Lennon, Ph.D. – President, Novartis Gene TherapiesBruce Levine, Ph.D. – Barbara and Edward Netter Professor in Cancer Gene Therapy, and Founding Director, Clinical Cell and Vaccine Production Facility, Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of PennsylvaniaJohn Maslowski, M.S. – President and CEO, Castle Creek PharmaceuticalsClaudia Mitchell, MBA, Ph.D. – SVP, Product and Portfolio Strategy, Astellas Pharma* Adora Ndu, PharmD, J.D. – VP, Regulatory Affairs, Policy, Research, Engagement & International, BioMarin* Susan Nichols – CEO, Falcon TherapeuticsEmile Nuwaysir, Ph.D. – President and CEO, BlueRock TherapeuticsMatthew Patterson (ex officio) – Strategic Advisor, Audentes Therapeutics, an Astellas CompanyJeff Ross, Ph.D. – CEO, Miromatrix MedicalCurran Simpson, M.S. – Chief Operating & Technical Officer, REGENXBIOSanjaya Singh, Ph.D. – VP and Global Head, Janssen BioTherapeutics, Janssen R&D, Janssen Pharmaceutical Companies of Johnson & JohnsonBob Smith, MBA – SVP, Global Gene Therapy Business, Pfizer Inc.Devyn Smith, Ph.D. – COO, Sigilon TherapeuticsJoe Tarnowski, Ph.D. – SVP, Cell and Gene Therapy Platform, GlaxoSmithKlineArthur Tzianabos, Ph.D. – President and CEO, Homology MedicinesGil Van Bokkelen, Ph.D. – Chairman and CEO, AthersysChristopher Vann – COO, Autolus TherapeuticsJason Wertheim, M.D., Ph.D. – Edward G. Elcock Professor of Surgical Research and Associate Professor, Division of Transplantation, Northwestern University* Kristin Yarema, Ph.D. – CCO, Atara BiotherapeuticsAbout the Alliance for Regenerative MedicineThe Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory and reimbursement initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options. Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 11-year history, ARM has become the global voice of the sector, representing the interests of 360+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups. To learn more about ARM or to become a member, visit http://www.alliancerm.org.Stephen Majors 404.630.8138 email@example.com
The "Metal Print Packaging - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a+" of most of MAPFRE S.A.’s (MAPFRE) rated operating subsidiaries. Concurrently, AM Best has upgraded the Long-Term ICR to "a+" from "a" of other rated operating subsidiaries, while affirming the FSR of A (Excellent). The outlook of these Credit Ratings (ratings) is stable. See below for a detailed listing of companies and ratings.
There's one route Terez Paylor is seeing every game on a weekly basis. Here's why it's so effective.